NVO advances obesity pipeline with CagriSema and Amycretin while expanding through major deals amid rising competition.

Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...

This one-time weight-loss drug leader has suffered several setbacks lately. It isn't wise to count out this veteran ...

Science Natural Supplements Berberine Sets New Standard for Weight Loss, Blood Sugar, and Gut Health Support NEW YORK CITY, ...

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

To discuss The Future of Scotch Whisky in Changing Times, McLaren Packaging, in association with The Scotsman, recently ...

To discuss The Future of Scotch Whisky in Changing Times, McLaren Packaging, in association with The Scotsman, recently ...

In the past, studies in type-2 diabetes patients have linked Ozempic to the condition called non-arteritic anterior ischemic ...

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...